Current Drug Targets
Title:Editorial (Thematic Issue: Glia: A New Cellular Target in the Treatment of Major Depression)
Volume: 14 Issue: 11
Author(s): Bruno Guiard
Affiliation:
Export Options
About this article
Cite this article as:
Guiard Bruno, Editorial (Thematic Issue: Glia: A New Cellular Target in the Treatment of Major Depression), Current Drug Targets 2013; 14 (11) . https://dx.doi.org/10.2174/13894501113149990207
DOI https://dx.doi.org/10.2174/13894501113149990207 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
36
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Common Neurogenetic Diagnosis and Meso-Limbic Manipulation of Hypodopaminergic Function in Reward Deficiency Syndrome (RDS): Changing the Recovery Landscape
Current Neuropharmacology Mechanism of CNS Drugs and their Combinations for Alzheimers Disease
Central Nervous System Agents in Medicinal Chemistry Application of Diet-derived Taste Active Components for Clinical Nutrition: Perspectives from Ancient AyurvedicMedical Science, Space Medicine, and Modern Clinical Nutrition
Current Pharmaceutical Design Induced Adaptive Resistance to Nitrooxidative Stress in the CNS: Therapeutic Implications
Central Nervous System Agents in Medicinal Chemistry Controversial Effects of Non-Steroidal Anti-Inflammatory Drugs on Bone: A Review
Inflammation & Allergy - Drug Targets (Discontinued) Exosomes: The Messengers of Health and Disease
Current Neuropharmacology A Review on Noscapine, and its Impact on Heme Metabolism
Current Drug Metabolism Dissecting the Mechanisms of Thrombogenesis and Atherosclerosis for Neurodegenerative Disorders
Current Neurovascular Research HIV-1-Associated Dementia During HAART Therapy
Recent Patents on CNS Drug Discovery (Discontinued) Curcumin Efficacy in a Serum/Glucose Deprivation-Induced Neuronal PC12 Injury Model
Current Molecular Pharmacology Editorial [ Hot Topic:Magic Bullets and Arrows: Biologic Approaches to Treat Substance Use Disorders (Guest Editor: Phil Skolnick and Nora D. Volkow)]
CNS & Neurological Disorders - Drug Targets Voltage-gated Sodium Channels in Sensory Information Processing
CNS & Neurological Disorders - Drug Targets The Many Faces of Tourette Syndrome
Current Drug Therapy Biomarkers Determining Cardiovascular Risk in Patients with Kidney Disease
Current Medicinal Chemistry Animal Models of Narcolepsy
CNS & Neurological Disorders - Drug Targets A PHACES Syndrome Unmasked by Propranolol Interruption in a Tetralogy of Fallot Patient: Case Report and Extensive Review on New Indications of Beta Blockers
Current Medicinal Chemistry Potassium Channel Blockers and Openers as CNS Neurologic Therapeutic Agents
Recent Patents on CNS Drug Discovery (Discontinued) Study of Splicing Factor, Proline- and Glutamine-rich by Proteomic Techniques in Human Malignant and Nonmalignant Cell Lines
Protein & Peptide Letters Experimental Methods for Studying the Interactions between G-Quadruplex Structures and Ligands
Current Pharmaceutical Design Voltage-Gated Sodium Channels in Neurological Disorders
CNS & Neurological Disorders - Drug Targets